Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05255705

Barts Revascularisation Registry

Despite the year-on-year decrease, coronary artery disease (CAD) still remains one of the leading cause of mortality worldwide. With advances in technology and our understanding of cardiac disease, we can now treat CAD using minimally invasive interventional techniques. This has revolutionised treatment for and improved the lives of many patients with CAD. Although trials have assessed various therapeutic strategies in various populations, real-world evidence of intervention and medical treatment among patients with CAD is increasingly recognised as an important part of providing safety and efficacy data and improving the care we provide.

This data will add to that literature by assessing the characteristics and outcomes of patients with CAD. It will also identify and characterise predictors of outcomes, improve risk stratification and diagnostic evaluation.

Recruiting

Interested in participating?

Request Info

Key information

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Barts Health NHS Trust

London, United Kingdom

Location status: Recruiting

Location contact

Dr Krishnaraj Rathod

CONTACT

About this study

The collection of data to describe the nationwide practice of percutaneous coronary intervention (PCI) in the UK started with the inception of the British Cardiovascular Intervention Society (BCIS) in 1988. From 1988 to 1991 annual surveys of PCI activity were published in the British Heart Journal. Annual reports from 1992 onwards are available for download from the society's website (http://www.bcis.org.uk), and summaries of some of the key data have been published as reports for distribution to participating hospitals and networks. The initial data collection process was essentially a descriptive survey of activity. Over time the process has evolved becoming more sophisticated with electronic methods for data collection developed by the Central Cardiac Audit Database (CCAD) group. The methods were tested in 1996 as a pilot in selected hospitals, and full UK-wide participation in the electronic collection of PCI data was achieved by 2005.

The proposed study includes one of the largest coronary interventional and surgical programmes in the UK at Europe's largest cardiac centre (BHC). This has allowed us to accumulate a large number of patients in just over 4 years. All patients undergoing PCI and CABG are included in this study using a clinical database. The database is password-protected and includes demographic, clinical and outcome data.

The database includes patients with simple to complex CAD. We will use this database to test several hypothesis including but not limited to investigating characteristics of patients treated, complications of interventional treatment and outcomes of patients. This research will add substantially to the literature by providing real-world data from a leading coronary centre.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes.
  • No children will be included in this study.
  • Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Interventional Cardiology team.
  • Both male and female patients ≥16 years of age will be included
  • All patients will have had an angiogram at BHC.
  • Any patient who has undergone revascularisation.

Exclusion criteria

  • Patients <16 years will not be included in this study.

Treatment and study plan

observation only

Other

Observation only

Primary outcomes

  1. Mortality

    Time frame: 1 year

    Assessment of Mortality

  2. Re-admission rates post Revascularisation

    Time frame: 1 year

    Re-admission

  3. MACE post Revascularisation

    Time frame: 1 year

    MACE

Study contacts

Contact information is provided by the study sponsor or research team.

Dr. Daniel Jones

CONTACT

[email protected]

02073777000

Dr. Krishnaraj Rathod

CONTACT

[email protected]

02073773000

Sponsors and collaborators

Lead sponsor

Queen Mary University of London

Other

Registry information

Official study title

Barts Revascularisation Registry - To Understand the Characteristics, Time-trends and Outcomes in Patients With Coronary Artery Disease at Barts Heart Centre

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Feb 24, 2022
Registry last updated
Jul 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.